Brief: Bajaj Healthcare Gets Approval From DCGI To Manufacture API And Drug Formulation Of Pimavanserin
Jan 30 (Reuters) - Bajaj Healthcare Ltd BAJH.NS :
* GETS APPROVAL FROM DCGI TO MANUFACTURE API AND DRUG
FORMULATION
OF PIMAVANSERIN
Source text: ID:
Further company coverage: BAJH.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bajaj Healthcare
See all newsBrief: Bajaj Healthcare Ltd Posts March-Quarter Loss 228.5 Million Rupees
Brief: Bajaj Healthcare Posts Dec-Quarter Profit Of 156.7 Million Rupees
Brief: Bajaj Healthcare Receives CDSCO Approval For Suvorexant Tablets Trial
India's Bajaj Healthcare rises as insomnia pill trial gets regulatory nod
Brief: Bajaj Healthcare Posts June-Quarter Profit Of 118.3 Million Rupees